ABBOTT AND ABBVIE: AN EXCITING NEW CHAPTER IN GLOBAL HEALTH
In January 2013, Abbott reached one of the most significant milestones in its celebrated history. Realizing that addressing the world’s evolving healthcare challenges requires focused solutions, delivery systems and approaches, Abbott separated into two independent companies: Abbott and AbbVie.
Abbott continues as one of the most far-reaching, diversified healthcare companies in the world, with a broad line of products and a strong presence in fast-growing, emerging markets. Whether developing new ways to deliver our proven medicines to people who need them; exploring the frontiers of nutrition science; advancing next generation devices; improving care for companion animals; or unlocking the secrets of gene-based diseases, Abbott will always be there—working toward a healthier, stronger world.
For more information, go to the Company Separation Press Kit.
AbbVie is a new, independent biopharmaceutical company composed of Abbott’s former proprietary pharmaceutical business. AbbVie is built on a legacy of advancing science to help treat complex diseases. AbbVie combines the strength and stability of an established pharmaceutical company with the focus and innovative spirit of a biotech.
Learn more at AbbVie.com